| 标题 |
Initial results of a phase 1 study of AMG 355, a novel anti-CCR8 antibody as a single agent and in combination with pembrolizumab in patients with solid tumors
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 其它 | Hollebecque A, et al. Initial results of a phase 1 study of AMG 355, a novel anti-CCR8 antibody as a single agent and in combination with pembrolizumab in patients with solid tumors. Cancer Res. 2026;86(8_Suppl):Abstract CT003(AACR 2026);ClinicalTrials.gov NCT06131398 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)